title: National Vitamin A Prophylaxis Programme: need for change in current age strategy.
abstract: Child survival and Safe Motherhood Programme emphasises on giving vitamin A prophylaxis upto three years of age only, contrary to earlier practice of its administration upto six years of age, based on the assumption of reduction of serious manifestations of vitamin A deficiency three years of age onwards. A cross-sectional study enrolling 1094 children was done to investigate vitamin A deficiency in under six children in urban slums of Nagpur city in Central India in post CSSM scenario. Clinical as well as subclinical (detected by abnormal conjunctival impression cytology) assessment of vitamin A status was performed according to standard procedures, as per WHO recommendations. The overall prevalence of xerophthalmia was 8.7%. Only milder manifestations of xerophthalmia were observed. Significantly higher prevalence of xerophthalmia was observed in more than three years of age. Although nonsignificant, higher prevalence of subclinical vitamin A deficiency was observed in above three years of age group. In view of current age strategy for vitamin A supplementation (< or = 3 years) and observed higher prevalence of clinical and subclinical vitamin A deficiency above three years of age in this study (also endorsed by earlier studies) a call for review of current age strategy for vitamin A supplementation is warranted.
authors.affiliation: Department of Preventive and Social Medicine, Govt. Medical College, Nagpur.
authors.forename: D W
authors.initials: DW
authors.lastname: Khandait
authors.forename: N D
authors.initials: ND
authors.lastname: Vasudeo
authors.forename: S P
authors.initials: SP
authors.lastname: Zodpey
authors.forename: D T
authors.initials: DT
authors.lastname: Kumbhalkar
authors.forename: M R
authors.initials: MR
authors.lastname: Koram
mesh_terms: D000367:Age Factors; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D006801:Humans; D007223:Infant; D015995:Prevalence; D015397:Program Evaluation; D014801:Vitamin A / Q000627:therapeutic use*; D014802:Vitamin A Deficiency / Q000453:epidemiology* / Q000517:prevention & control; D014985:Xerophthalmia / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D014801:Vitamin A